Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig

Huadong Tang1, Yvonne Pak, Michael Mayersohn

  • 1Department of Pharmacy Practice and Science, Arizona Center for Phytomedicine Research, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.

Insights

P-glycoprotein (P-gp) levels increase along the Yucatan micropig

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Animal Models

Background:

  • Yucatan micropigs are a developing model for human drug bioavailability studies.
  • Understanding drug transporter distribution is crucial for predicting absorption and efficacy.
  • P-glycoprotein (P-gp) significantly influences drug absorption and efflux.

Purpose of the Study:

  • To map the distribution of P-gp protein across the entire gastrointestinal (GI) tract of the Yucatan micropig.
  • To establish the Yucatan micropig as a relevant preclinical model for drug disposition studies.

Main Methods:

  • Harvesting and segmenting the small and large intestines of Yucatan micropigs.
  • Isolating epithelial cells using elution (small intestine) and scraping (large intestine) methods.
  • Quantifying P-gp protein levels via Western blot analysis.

Main Results:

  • P-gp protein expression demonstrated a significant distal increase from duodenum to ileum in the small intestine (approx. 10-fold range).
  • Higher P-gp levels were observed in the central portion of the large intestine compared to its ends.
  • Absolute P-gp amounts in the large intestine were considerably lower than in the small intestine.

Conclusions:

  • The Yucatan micropig exhibits a distinct, segment-specific distribution pattern of P-gp in the GI tract.
  • This characterized P-gp distribution supports the Yucatan micropig's utility in preclinical drug bioavailability research.
  • Findings provide essential data for pharmacokinetic modeling and drug development using this animal model.

Related Concept Videos